SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Erkeller-Yuksel, F.
Right arrow Articles by Isenberg, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Erkeller-Yuksel, F.
Right arrow Articles by Isenberg, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Lack of NK cells in lupus patients with renal involvement

FM Erkeller-Yuksel

Centre for Rheumatology/Bloomsbury Rheumatology Unit, Department of Medicine and Department of Immunology, University College, London

PM Lydyard

Department of Immunology, University College, London

DA Isenberg

Centre for Rheumatology/Bloomsbury Rheumatology Unit, Department of Medicine and Department of Immunology, University College, London

We have previously shown that patients with SLE have significantly lower percentages and absolute numbers of NK(CD3-/CD16+56) cells in their peripheral blood compared with normals.1 Patients with active disease had very low levels of NK cells and the reduction was also associated with patients who had renal involvement. We have now performed a serial study immunophenotyping 11 patients with SLE and renal involvement using dual colour immuno flourescence and flow cytometry. Patients were tested every three months on an average of three occasions. As a control, nine SLE patients without renal involvement were immunophenotyped for similar intervals; 11 normal controls were also tested.

Major lymphocyte subsets (T, B and NK) remained very stable during serial bleeds. However, the NK cell populations were decreased significantly in patients with renal involvement both as percentages (5±6 vs 9±5, P<0.0001) and absolute counts (75±108 vs 109±52, P<0.001) in comparison to non-renal patients. Analysis of disease activity using BILAG score showed an inverse correlation between renal system activity and percentage and absolute number of NK cells (P<0.002 and 0.01, respectively).

In this study we have also analysed a CD8 T cell subset which we have not studied before. We have found a significantly increased percentage of CD38+ CD8+ T cells(activated CD8 subset) in patients with SLE in comparison to normal controls. We did not find any association with the CD38 + CD8 + T cells and disease activity as measured by BILAG or renal involvement.

NK cells are important factors in immunity against virus infections and tumour cells. CD38 +CD8+T cells are increased in viral infections. We speculate that the lack of NK cells in SLE patients might have an association with increased CD38 expression.

Key Words: renal involvement • NK cells • CD38 + CD8 T cells

Lupus, Vol. 6, No. 9, 708-712 (1997)
DOI: 10.1177/096120339700600905


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
R. A. Zeuner, D. M. Klinman, G. Illei, C. Yarboro, K. J. Ishii, M. Gursel, and D. Verthelyi
Response of peripheral blood mononuclear cells from lupus patients to stimulation by CpG oligodeoxynucleotides
Rheumatology, April 1, 2003; 42(4): 563 - 569.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
V Riccieri, A Spadaro, G Parisi, E Taccari, T Moretti, G Bernardini, M R Favaroni, and R Strom
Down-regulation of natural killer cells and of g/d T cells in systemic lupus erythematosus. Does it correlate to autoimmunity and to laboratory indices of disease activity?
Lupus, June 1, 2000; 9(5): 333 - 337.
[Abstract] [PDF]



Advertisement